Physician profile
Cole Hicks
NPI 1144912387
$643.90
in general payments reported to CMS, 2019-2025
16 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $126 · 2024: $377 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $158.24 | 2024-2025 | Lifevest |
| Boston Scientific Corporation | $111.12 | 2023-2025 | Angiojet Ultra 5000a, Ekosonic, Epic Vascular |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.27 | 2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $60.34 | 2024 | |
| Kestra Medical Technology Services, INC. | $35.88 | 2024 | Assure Wcd |
| Edwards Lifesciences Corporation | $34.24 | 2024 | Pascal |
| Astrazeneca Pharmaceuticals LP | $26.87 | 2023-2024 | Farxiga |
| Surmodics, INC. | $19.61 | 2023 | Pounce Thrombectomy, Sublime Radial Access Guide Sheath, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Kiniksa Pharmaceuticals International, Plc | $17.24 | 2024 | Arcalyst |
| Abiomed | $16.82 | 2024 | Impella |
| Janssen Pharmaceuticals, INC | $16.17 | 2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $15.67 | 2024 | Camzyos |
| Bard Peripheral Vascular, INC. | $15.60 | 2023 | Crosser Iq |
| Merck Sharp & Dohme LLC | $15.18 | 2024 | Verquvo |
| Amgen INC. | $14.34 | 2024 | Repatha |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.31 | 2024 | Linq II |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cole Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.